CURE OM - Leading Research on Ocular and Uveal Melanoma
The MRF's CURE OM initiative is leading the ocular melanoma (OM) field forward. We are committed to accelerating the development of effective treatments and, ultimately, a cure for this disease. Our scientific initiative is led by our international, interdisciplinary Scientific Steering Committee and includes research grants, biannual international scientific meetings and partnerships with leading organizations, including industry. These efforts ensure continued collaboration, support and coordination to move OM research forward.
The 2016 Request for Proposals (RFP) is now available! Applications will be accepted from January 1 - March 1, 2016. Applications will be submitted and managed entirely online through ProposalCENTRAL. The RFP will be made available on ProposalCENTRAL on January 1, 2016. Learn how to apply HERE!
This year, CURE OM is excited to announce two award opportunities:
CURE OM Junior Fellowship Award, funded by an educational grant from AstraZeneca
In 2016, the MRF will offer a CURE OM Junior Fellowship Award, funded by an educational grant from AstraZeneca. This award will provide funding of $50,000 per year for two years to a junior investigator focusing on ocular melanoma. Researchers who are beginning a research career focused on ocular melanoma and have not yet established strong federal funding for their research are eligible.
CURE OM Unite! Established Investigator Award
The CURE OM Unite! Campaign was launched in May 2015 to bridge the gap between patients and researchers. This one-of-a-kind EIA is directly funded by the CURE OM patient and family community. The funding has come largely through CURE OM teams in Miles for Melanoma 5k run/walks around the country, as well as all general CURE OM Unite! donations received during the campaign period. An inspired donor matched this fundraising to create the award. This award will provide funding of up to $100,000 per year for two years to an established ocular melanoma researcher. This unique opportunity will include a patient review panel in addition to the MRF’s standard, expert, peer-reviewed panel, allowing the patient perspective to be considered in the critique process.
In 2012, CURE OM began funding ocular melanoma-specific research grants. Falling under the MRF's general Research Grant Program, the research emphasizes both basic and clinical research projects that explore innovative approaches to understanding OM and its treatment. Proposals are submitted from around the world and undergo a rigorous peer-reviewed process by experts and leaders in the OM field. This helps us identify the most promising and impactful research to fund. In the first 2 years, we have secured over $800,000 specifically for OM research and have funded 4 different research recipients. Please read about the CURE OM grant recipients or learn about all of the MRF's previous award winners.
CURE OM hosts biannual international scientific meetings aimed at increasing collaboration in the OM field in order to accelerate treatment and research. Each meeting includes a diverse group of speakers and participants from around the world.
CURE OM has established important partnerships with leading research organizations, including the National Cancer Institute, the Society for Melanoma Research and the International Rare Cancers Initiative, just to name a few! We also work regularly with leading melanoma research institutions all over the world. Together, we are leading the way in finding a cure for ocular melanoma.